Guo‐Bo Li
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Chemical Synthesis and Analysis 9
-
- Synthesis and biological activity 8
- Co-authors
- Lingling Yang (30 shared papers)Shengyong Yang (23 shared papers)Yu‐Hang Yan (22 shared papers)Linli Li (7 shared papers)Qing-Qing Dai (10 shared papers)Yong Wu (16 shared papers)Junlin Yu (9 shared papers)Wenjing Wang (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (15 papers)European Journal of Medicinal Chemistry (12 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)RSC Advances (4 papers)Chemical Communications (3 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Guo‐Bo Li
112 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 137
- Geriatrics and Gerontology 223
- Molecular Medicine 338
- Physiology 109
- Biological Psychiatry 54
- Organic Chemistry 646
Countries citing papers authored by Guo‐Bo Li
This map shows the geographic impact of Guo‐Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Bo Li more than expected).
Fields of papers citing papers by Guo‐Bo Li
This network shows the impact of papers produced by Guo‐Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Bo Li. The network helps show where Guo‐Bo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guo‐Bo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 142 | |
| 2 | 2018 | 97 | |
| 3 | 2020 | 95 | |
| 4 | 2021 | 84 | |
| 5 | 2015 | 67 | |
| 6 | 2013 | 65 | |
| 7 | 2016 | 62 | |
| 8 | 2017 | 61 | |
| 9 | 2016 | 61 | |
| 10 | 2021 | 58 | |
| 11 | 2018 | 55 | |
| 12 | 2018 | 50 | |
| 13 | 2018 | 48 | |
| 14 | 2019 | 48 | |
| 15 | 2020 | 47 | |
| 16 | 2021 | 47 | |
| 17 | 2020 | 46 | |
| 18 | 2023 | 44 | |
| 19 | 2017 | 42 | |
| 20 | 2015 | 42 |
About Guo‐Bo Li
Guo‐Bo Li is a scholar working on Molecular Biology, Organic Chemistry, Molecular Medicine, Epidemiology and Oncology, having authored 119 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (17 papers), Computational Drug Discovery Methods (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), Sirtuins and Resveratrol in Medicine (10 papers), Chemical Synthesis and Analysis (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Synthesis and biological activity (8 papers) and Calcium signaling and nucleotide metabolism (6 papers). The work is most often cited by research in Geriatrics and Gerontology (223 citations), Molecular Medicine (338 citations), Physiology (109 citations), Biological Psychiatry (54 citations) and Organic Chemistry (646 citations). Guo‐Bo Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Lingling Yang, Shengyong Yang, Yu‐Hang Yan, Linli Li, Qing-Qing Dai, Yong Wu, Junlin Yu, Wenjing Wang, Zhujun Yu and Christopher J. Schofield. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, RSC Advances and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.